Top Cited Articles
Creator:   Editorial Office
Created:   7/12/2012
Contains:  25 items
A selection of top-cited articles in 2011

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

Rallón, Norma I; Naggie, Susanna; Benito, José M; More

AIDS . 24(8):F23-F29, May 15, 2010.

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

Simioni, Samanta; Cavassini, Matthias; Annoni, Jean-Marie; More

AIDS . 24(9):1243-1250, June 1, 2010.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

Marra, Christina M; Zhao, Yu; Clifford, David B; More

AIDS . 23(11):1359-1366, July 17, 2009.

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

Smith, Kimberly Y; Patel, Parul; Fine, Derek; More

AIDS . 23(12):1547-1556, July 31, 2009.

Continuous antiretroviral therapy decreases bone mineral density

Grund, Birgit; Peng, Grace; Gibert, Cynthia L; More

AIDS . 23(12):1519-1529, July 31, 2009.

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis

Mills, Anthony M; Nelson, Mark; Jayaweera, Dushyantha; More

AIDS . 23(13):1679-1688, August 24, 2009.

Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study

Grunfeld, Carl; Delaney, Joseph AC; Wanke, Christine; More

AIDS . 23(14):1841-1849, September 10, 2009.

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

Katlama, Christine; Haubrich, Richard; Lalezari, Jacob; More

AIDS . 23(17):2289-2300, November 13, 2009.

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

Arribas, Jose R; Horban, Andrzej; Gerstoft, Jan; More

AIDS . 24(2):223-230, January 2010.

High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients

Mueller, Nicolas J; Fux, Christoph A; Ledergerber, Bruno; More

AIDS . 24(8):1127-1134, May 15, 2010.

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

Meintjes, Graeme; Wilkinson, Robert J; Morroni, Chelsea; More

AIDS . 24(15):2381-2390, September 24, 2010.

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line...

Hosseinipour, Mina C; van Oosterhout, Joep JG; Weigel, Ralf; More

AIDS . 23(9):1127-1134, June 1, 2009.

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

Boulle, Andrew; Van Cutsem, Gilles; Hilderbrand, Katherine; More

AIDS . 24(4):563-572, February 20, 2010.

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.–2006

Wheeler, William H; Ziebell, Rebecca A; Zabina, Helena; More

AIDS . 24(8):1203-1212, May 15, 2010.